Schedule a Consultation
For PatientsContact Us โ†’
Contact Us

Chronic Kidney Disease Care Management With Medication Expertise Built In

Support kidney health through proactive disease management, renal-focused medication review, coordinated follow-up, and attention to the barriers affecting everyday care.

Clinician checking blood pressure for an older adult patient during a home healthcare visit
Older adult participating in a virtual care consultation from home

CKD Requires Continuous Attention Between Visits

Chronic kidney disease affects approximately 37 million U.S. adults, and most people with CKD are unaware they have it. The condition frequently occurs alongside diabetes, hypertension, cardiovascular disease, and other chronic conditionsโ€”making medication management and cross-specialty coordination especially important.

As kidney function changes, medication safety and dose appropriateness may also change. At the same time, blood pressure control, diabetes management, nutrition, follow-up testing, and preparation for more advanced disease require sustained patient engagement.

PharmD Live helps nephrology practices, primary care organizations, ACOs, IDNs, health systems, and payers extend kidney-focused care beyond the office visit through a multidisciplinary, virtual care model.

Three Integrated Dimensions of CKD Care

Disease Management

The team supports the treating providerโ€™s care plan through patient education, monitoring follow-up, care-gap identification, comorbidity management, and coordination across nephrology, primary care, cardiology, endocrinology, and other involved clinicians.

Care is tailored to disease stage, comorbidities, recent utilization, and the patientโ€™s ability to participate. Education may include the importance of ordered laboratory testing, blood pressure monitoring, symptom reporting, medication adherence, and following nutrition guidance from the treating clinical team.

Older adult checking blood pressure at home
Clinician explaining medication to an older adult patient

Clinical Pharmacist-Led Medication Management

Clinical pharmacists review prescription medications, over-the-counter products, and supplements in the context of kidney function, diagnoses, laboratory information, and the overall treatment plan. Reviews may identify:

  • Potential renal-dose concerns

  • Medications requiring additional monitoring

  • Potentially nephrotoxic exposure

  • Drug interactions and therapeutic duplication

  • Adherence, affordability, and refill barriers

  • Polypharmacy and medication-burden concerns

  • Opportunities to discuss kidney- and cardiovascular-protective treatment with the prescriber

PharmD Live communicates informed, guideline-driven recommendations to the prescriber. The prescriber makes all prescribing, discontinuation, substitution, and dose-adjustment decisions.

Social Determinants of Health Support

Kidney disease can be difficult to manage when patients lack transportation, medication coverage, appropriate food, caregiver support, stable housing, health literacy, or access to monitoring and telehealth technology. PharmD Live identifies relevant barriers and supports resource coordination in collaboration with the patientโ€™s care team.

Caregiver helping an older adult use a digital tablet during a home healthcare visit

Program Capabilities

Renal-focused comprehensive medication review

Medication reconciliation after hospital or emergency care

Blood pressure and diabetes monitoring support when included in the care plan

Follow-up for ordered testing and preventive care gaps

Adherence and medication-access support

Education reinforcing the nephrologistโ€™s and primary care clinicianโ€™s plan

Coordination across specialists and care settings

Post-discharge transitional care

Support for patients approaching advanced CKD or kidney-replacement planning, as directed by their treating providers

Quality and Performance Priorities

The program is designed to support:

Blood pressure management

Diabetes and cardiovascular risk management

Medication safety as kidney function changes

Identification of potentially avoidable nephrotoxic exposure

Timely follow-up and care-plan adherence

Fewer potentially avoidable acute-care episodes

Greater patient understanding and engagement

Better coordination across nephrology and primary care

Lower avoidable total cost of care in high-risk CKD populations

Clinician discussing a treatment plan with older adult patients

Demonstrated Value in Nephrology

In a featured nephrology chronic care management engagement, PharmD Live delivered $8.6 million in healthcare cost avoidance, $3.50 returned for every $1 invested, and a +91 Net Promoter Score.

$8.6 millionin healthcare cost avoidance
$3.50returned for every $1 invested
+91Net Promoter Score

The results reflect the value of sustained, patient-centered care that combines chronic disease support, clinical pharmacist medication expertise, and coordinated follow-up. Results vary by population, baseline performance, enrollment, program design, and implementation.

Who the Program Serves

Older adult using a tablet as part of virtual kidney-focused care

Nephrology groups extending support between visits

Primary care organizations managing early-stage CKD

ACOs and IDNs addressing high-cost CKD populations

Hospitals and health systems improving post-discharge continuity

Medicare Advantage plans and other payers focused on kidney health, adherence, utilization, and total cost of care

Frequently Asked Questions

Which CKD populations can PharmD Live support?

The program can be configured for patients across CKD stages, including patients with diabetes or hypertension, patients with complex medication regimens, recently discharged patients, and patients requiring closer coordination with nephrology. Final eligibility and care intensity are established with the client and treating providers.

Does PharmD Live change renal medication doses?

No. Clinical pharmacists assess the medication regimen in the context of available kidney-function information and provide guideline-driven recommendations to the prescriber. The prescriber makes all therapy decisions.

How are social barriers addressed?

The team screens for relevant barriers such as medication affordability, transportation, food access, health literacy, technology access, and caregiver support. Identified needs are communicated and addressed through available organizational and community resources.

Can the program support both nephrology and primary care workflows?

Yes. Workflows are designed around the organization, population, and authorized care team so that relevant findings reach the appropriate clinician.

Extend Kidney-Focused Care Beyond the Clinic

Build a coordinated program around the clinical, medication, and social factors influencing CKD outcomes.

Discuss Your CKD Population View the Nephrology Results